← Back to Clinical Trials
Recruiting NCT07654959

NCT07654959 Test Anxiety on Bowel Health and Constipation in Students

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07654959
Status Recruiting
Phase
Sponsor Lokman Hekim University
Condition Anxiety
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2026-02-25
Primary Completion 2026-08-25

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Observational assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2026-02-25 with a primary completion date of 2026-08-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational cross-sectional study aims to examine the relationship between test anxiety, bowel health, and constipation in university students. The study will include undergraduate students aged 18 years and older who are studying in the Physiotherapy and Rehabilitation Department at Lokman Hekim University and who are in their final examination period. Participants will complete self-report questionnaires during a single face-to-face assessment session. Constipation status will be evaluated using the Rome IV criteria, stool form will be assessed using the Bristol Stool Scale, constipation severity will be assessed using the Constipation Severity Instrument, and test anxiety level will be assessed using the Test Anxiety Inventory. Sociodemographic characteristics and bowel-related symptoms will also be recorded. The study does not include any intervention or treatment. The findings are expected to help better understand whether test anxiety during examination periods is associated with bowel health problems and constipation in university students.

Eligibility Criteria

Inclusion Criteria: * Being an undergraduate student in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University * Being in the final examination period during the data collection process * Having sufficient reading and comprehension skills to complete the questionnaires independently * Voluntarily agreeing to participate in the study after reading and signing the informed consent form Exclusion Criteria: * Having inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, celiac disease, colorectal cancer, or a history of major gastrointestinal surgery * Having diagnosed irritable bowel syndrome or another organic gastrointestinal disease * Regular use of laxatives or medications that directly affect bowel movements, such as opioids * Having neurological diseases that may affect bowel function, such as multiple sclerosis, Parkinson's disease, or spinal cord injury * Having had an acute gastrointestinal infection within the last month

Contact & Investigator

Central Contact

Demet Öztürk, Phd

✉ demett.ozturkk@gmail.com

📞 +905068394288

Frequently Asked Questions

Who can join the NCT07654959 clinical trial?

This trial is open to participants of all sexes, studying Anxiety. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07654959 currently recruiting?

Yes, NCT07654959 is actively recruiting participants. Contact the research team at demett.ozturkk@gmail.com for enrollment information.

Where is the NCT07654959 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT07654959 clinical trial?

NCT07654959 is sponsored by Lokman Hekim University. The trial plans to enroll 200 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology